Leidos (NYSE:LDOS – Get Free Report) had its price objective hoisted by investment analysts at Citigroup from $141.00 to $163.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the aerospace company’s stock. Citigroup‘s price target would suggest a potential upside of 18.31% from the company’s […]

American Healthcare REIT (NYSE:AHR – Get Free Report) had its price target hoisted by stock analysts at Citigroup from $65.00 to $67.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup‘s price objective suggests a potential upside of 13.32% from the stock’s current […]

IGM Financial (TSE:IGM – Get Free Report) had its target price upped by stock analysts at Desjardins from C$93.00 to C$94.00 in a research note issued on Monday, BayStreet reports. The brokerage currently has a “buy” rating on the financial services provider’s stock. Desjardins‘s price target would indicate a potential upside of 9.23% from the […]

Extendicare (TSE:EXE – Get Free Report) had its price target increased by Desjardins from C$39.00 to C$39.50 in a research report issued to clients and investors on Monday, BayStreet reports. The firm currently has a “buy” rating on the stock. Desjardins‘s price target would indicate a potential upside of 40.32% from the stock’s current price. […]

Edwards Lifesciences (NYSE:EW – Get Free Report) had its target price raised by investment analysts at Citigroup from $110.00 to $117.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. Citigroup‘s price target would suggest a potential upside of 14.81% […]

Block (NYSE:XYZ – Get Free Report) had its price target increased by analysts at UBS Group from $96.00 to $105.00 in a report issued on Tuesday. UBS Group‘s target price suggests a potential upside of 21.85% from the stock’s previous close. A number of other brokerages have also weighed in on XYZ. Scotiabank boosted their […]

Fortune Brands Innovations (NYSE:FBIN – Get Free Report) had its price target raised by Citigroup from $48.00 to $56.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup‘s price target points to a potential upside of 16.65% from the stock’s previous close. A […]

Mplx (NYSE:MPLX – Get Free Report) had its price objective raised by investment analysts at Citigroup from $55.00 to $56.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the pipeline company’s stock. Citigroup‘s target price suggests a potential downside of 0.92% from […]

Pursuit Attractions and Hospitality (NYSE:PRSU – Get Free Report) had its price objective raised by investment analysts at Oppenheimer from $58.00 to $65.00 in a report released on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer‘s target price indicates a potential upside of 25.73% from the company’s current price. […]

Hyatt Hotels (NYSE:H – Get Free Report) had its price target lifted by analysts at Freedom Broker from $192.00 to $206.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Freedom Broker‘s price target points to a potential upside of 10.91% from the […]

Enhanced Group (NYSE:ENHA – Get Free Report) had its target price increased by equities researchers at Canaccord Genuity Group from $5.00 to $17.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group‘s price objective suggests a potential upside of 80.56% from the […]

GFL ENVIRON-TS (CVE:GFL – Get Free Report) had its price objective increased by equities research analysts at ATB Cormark Capital Markets from C$87.00 to C$88.00 in a research note issued on Sunday, BayStreet reports. The brokerage currently has an “outperform” rating on the stock. Other research analysts also recently issued research reports about the company. […]

Visa (NYSE:V – Get Free Report) had its price objective hoisted by equities research analysts at Barclays from $420.00 to $440.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the credit-card processor’s stock. Barclays‘s target price would suggest a potential upside of 9.50% from the stock’s […]